industry

Cassava Sciences Inc

action

The day to day price action of this limp dick is more painful to watch than slugs breeding.

$SAVA , this daily one way action is depressing.

Zero confidence in management based on both recent actions and historical issues with the FDA. 2.

$SAVA We may get frustrated with volatility, manipulation, and irregular daily price action

price

This is sickening that these crooks can manipulate the price like this. !!!

He invites shorts to destroy stock price.. pathetic!

Some had to drop in price a little first!

new employee mr. cook must be pissed as this is lower price than the shares he got it for.

All.u did was dilute the pps 
..and release to prs to kill the stock price and momentum  
 You did so well..you fxuking scumbag.

I hate the stock price runup leading to an announcement.

data

- 
$AVXL in comparison, boring as hell - whenever Missling talks people fall asleep and holding back data and further readouts without any logical explanation are red flags -

$SAVA 
Pyggie here was bullish a few days ago, folded like a pussy because he can’t read data, and now spews FUD, like a spoiled child, because he’s worried he may have paper-handed a monster.

but offer only the “opinion” that there was “possible data manipulation.”

$SAVA longtime biotech investor and my honest experience when a CEO promises good data and there is a long waiting period = not good.

Sentiment matters in this game, and unfortunately, this company has been drug through the mud for so long that good data might just get overlooked.

$SAVA The ironic and sad thing is that this ticker has been abused and manipulated so badly that even if it triples on upcoming data release it still won&#39;t come close to ATH achieved on much less evidence of safety and efficacy.

The CEO belongs in jail with all this pump and dump stock manipulation and data manipulation

just annoying we all get so worked up and insulting when we, the retail investor, can neither move Remi to release data early or in truth, move the SP by buying or selling a few hundred shares.

$SAVA dumb management causing longs to lose confidence, you dont change the date of data release every few weeks, just give a date when you are certain and stick with that, its that simple

BIIB with a 27% chance of no decline - so bad, how can they even publish data like that.

patient

however, if you are a family member of Alz patient think about how fatiguing emotionally and financially it is to change diapers, have your name forgotten, or even have to take a license away from an otherwise healthy person.

but your day will come when you will pay back way more than the damage you have caused and the lives you have threatened from being treated for a debilitating disease.

$ALZN $ATHA $ORMP $SAVA $SPRC yes then go back to your scam board clown no need to trap others in this scam .. we know what value SAVA brings to their AD patients

Lecanemab approved - IV  infusion..increased infection risk, inconvenient for patients with MD&#39;s fully aware 
of side effects: brain swelling and bleeding. 2.

Eventually, the  
AD patient is unable to perform daily functions.

But the monoclonal antibody treatment also carries risks of brain swelling and bleeding.

$BIIB - lied and tried to push their bad drug Aduhelm on unsuspecting patients (one of which is a family member of mine).

3 deaths in 1900 trial patients.. how many deaths is our FDA going to inflict on millions of folks who are supposed to take this death drugs that also happen to have near-zero efficacy?? SMH

Avxl, not good they didn&#39;t have an agreement in place “plan for approval“ before they started the test fase 2b 500 patients.

$SAVA It&#39;s not only CRUEL for anyone to be prescribing any of these MABs for AD patients, it&#39;s impractical for both patients and the healthcare system in general.

application

$SAVA Words  to  to  ignorant,  never  hype  a  employee  from  fda,  shady  shiat! 🤡🤡🤡😂😂😂

It doesn&#39;t matter if drugs for terminal illnesses, have been approved after 6 months, because there is endless manipulation here, and this waiting game is based on either FDA approval or denial based on corruption at the agency?

This is such crap with the FDA my Father died a year ago from it

$BIIB $SAVA You would need uncommon patience to not be crazy mad at the system for this shenanigan approval process and decision from the FDA.

Idiots with no respect for integrity continues  to run 
wild within the FDA.

$SAVA once again we got fu*ked by the evil BIIB + FDA.

$SAVA THIS is how corrupt our FDA and state medical boards are.

$BIIB $SAVA  
I tell ya why - FDA is corrupt deep in its root, period!

Biogens drug really lowered the bar for everyone in the industry which is great..

$SAVA Simufilam - can meet the &quot;biggest&quot; unmet need in the pharmaceutical industry of this century!

$CDTX FDA decision will be made tomorrow $SAVA, $MDGL &amp; $RETA boys I can easily see this up 200%-300% in my opinion on an approval.

$SAVA FDA approved Biogen&#39;s AD drug is bullish for SAVA.

no more speculation, now it&#39;s real, two FDA approved meds, two major products, top of the line in comparison of their rivals, for cheaper price, AND WITH NO MUCH COMPETITION!

$SAVA When FDA approved Aduhelm (aducanumab), which was a failure, on June 7 2021, SAVA was up 33% within a day following that news! !

My prediction:
Phase 2 Unbelievable results
FDA fast track
Phase 3 - go ahead
Patients receive sava 
Market cap 40 B by 2024 
Rising to 200 Billion by 2026
Game changer - the only drug in the world to help patients

This formula has already proved to be effective, and if FDA approved can potentially be sold for billions.

$SAVA the drug is 100% safe the fda has nothing to lose if they approve it for compassionate use.

Should be place on fast track by the FDA!

business-result

But the company actually has never seen before wonderful results.

And, make no mistake, the result are impressive.

It is the best results that have been seen in AD.

This could be huge in eliminating artificial FUD against the top-line results.

$SAVA Market is moving higher as SAVA is expecting data results.

Anavex is late like the sun comes up and still produces great results.

MOST IMPORTANTLY, THE RESULTS MUST HAVE BEEN GOOD AND PROMISING at each snapshot that leads Remi to use the word &quot;Thrilled&quot; in Dec 6 PR.

Data tells me no safety issues, with a possible large therapeutic window.

Then they dropped the “good” totally “not disappointing” data that Remi was so “Thrilled” about.

This will go beyond parabolic on good data … literally no shares out there unless they offer new ones … $MDGL $VKTX $SLS $SAVA

SAVA data gets analyzed by multiple different labs and shows its cognition improvement in mild AD cases, safe and well-tolerated

$SAVA I love not being able to hold $28 off data that will keep it pinned here until 2024.

but the data to date would predict continued efficacy that will be nigh on impossible to ignore.

$SAVA Institutional buying says data is good!! !

I’ll keep buying until data comes out…

Excited for the next data unveiling….bring it on!

$SAVA “Treatment also eased depression and dementia-related behaviors in patients, two exploratory trial goals, and simufilam was found to be safe and well tolerated.”

This will bring in billions of revenue and it will make the life quality longer for AD patients.

This sub-set of patients improved -4.96 mean points on ADAS-Cog from baseline to month 12.

CURING LEUKEMIA isn&#39;t a fly by night thing with Gamma T Cells and they already have ONE COMPLETE RESPONSE curing someone in Stage 4 nonresponsive to other treatments!

$SAVA this is going to be game changer and first drug to give some relief to AD patients … and will make $BIIB poison AD pills an obsolete

The high number of the patients that went into CMS (which is 80% complete) is reassuring.

but reverses cognitive decline and improves quality of life for the patient AND the FAMILY!

but mostly new hope for all the families and patients with AZ.

Testing still continues, so in my way of thinking the real-world results in patients must be nothing short of excellent.

Aurinia Pharmaceuticals Inc

bear

$AUPH ladies, gentlemen and everything in between or neither, this is what you call a bear trap

$AUPH smells like a bear trap like yesterday.

Not Achieved - Protect the companies intellectual property and do not put it at risk with a patent troll lawsuit for pennies.

$AUPH Neil and Robert could not have been to happy with Peter and his patent troll antics.

hold

$AUPH ZURA is up +300% and this shit cant even hold $9

I can&#39;t believe the lack of communication from this team. Hold the carrot out in front (partnership, spokeperson, stockholder value.  )

Seriously, what is his excuse this year to hold a meeting where there is no opposition voices?

They never hold gains especially this one with its history and management team

Stock price is like drunk person, cant hold any gains, always falling

Almost 2 years of wasted time no matter how long they’ll hold onto patent.

life

They could take your identity and mess your life up.

That’s how they live their lavish life at the expense of retails.

Expect a total non-sense of options gift for a gang of crooked m***f*** lazy asses that only burnt 2 years of our lives with mistaken strategies and very poor choices.

Wrong for your whole life and all your calls.

You are evil and continue to kill so many lives because you could not and will not be able to ramp up sales better than BP.

$AUPH 

This SOB CeO made everyone’s life a living hell.

To be honest I have never seen in my entire life  a company with such troubles who does not communicate and also a CEO who is not defending its SP.

It’s mind boggling how this is allowed to continue, especially with a patent life now at risk of being severely crippled.

- Lupkynis Price +8 % in Dec 
- Erol is Magnificent 
 
Bad: 
- Sell the fucking Company!

$AUPH Producer price index is in and not looking good.

$AUPH WTF is going on here, why all the push for good news and share price made a small move up and now it’s going to be all given back, illegal options granting, at least it should be is that why we are dropping

$AUPH poor management, proven price manipulation, sell all before the final collapse

Regardless of whatever you discuss, the price is halted.

sale

barely any advertising, terrible sales, no direction, no hunger, no work ethic.

$AUPH Unhappy with 
-&gt; 50%+ dilution in last 36 m.
-&gt; Poor performances in sales and market penetration, absurd bonuses paid to management…
-&gt; Misleading statements, promises from mgmt whom does not deliver… 

You know what to do @ 23 AGM!

This crap won&#39;t change until new leadership is in place or better ending like sale of the company.

The only thing left to do is whine and complain about sales, management, and lack of a buyout.

Greenleaf doesn’t have the experience or knowledge to make sales grow.

NOT growing sales for 3 quarters and losing money at a faster rate is not the path of a successful company.

$AUPH what the hell is wrong with this company, CEO can’t get the ball rolling, either sell the company or put in some real effort trying to advertise Lupkynis, to boost sales.

The value of the asset in PGs hands shrinks month by month as their sales numbers stink up the room.

This will be a huge game changer for whole industry as well as patients not on insulin. 👍

$ARHS reported higher than expected revenue, raised fy22 guidance by 6% I am ‘encouraged’ by the company&#39;s execution as it keeps capturing white space in a fragmented industry.

I now have total confidence in the SEC and the financial industry.

Only FDA EMA approved oral drug for LN w 3 years safety history,  which shows clear improvement in eGFR compared to placebo.

I think this drug will likely be BO before FDA APPROVAL 

13% up just for today!

news

$AUPH Good news for investors  Options Flow 🤖 analysis shows upward momentum.

I guarantee if the company announced a new CEO, SP instantly rises 20% on the news alone…

$AUPH  Great news would be partnering with BMY, GSK etc… not waiting this inept CEO to tell you someone is going to help him out with marketing.

$AUPH  I believe we will see some positive news this week.

$AUPH looks like we hv triple good news.. 
1.SVB out of the way
2.

Usually good news for auph comes at a time when the market shits the bed.

With heavy intel networks, tutes or a group of individuals taking this up north, expecting some major positive news.

$AUPH I have listed 9 catalysts, which gives me confidence its share price will move higher.

Peter and BoDs got RSU recently and they want to stock price to go 🆙 ⬆️

The price in low and has lots of potential. So.

$AUPH 10 looks pretty even if it is the AH price.

are actually buys, since they are the same price as 2 minutes before

Share price is above all simple and exponential moving averages from 10d to 200d too.

$AUPH Nice price action on lower then 10 day volume average.

.very interesting spikes in the stock price

Its actually positive that &quot;they&quot; r not letting the price drop precipitously.

longs

Next few hours should be interesting for us longs as that just may happen here.

Meanwhile I will be enjoying the dance videos til it happens. GL to all longs and shorts :-)

$AUPH things are looking up for us longs here again!

Things are going to improve for hardheaded AUPH longs.

$AUPH Have a nice Thanksgiving everyone, things are going to get better for all of us longs.

$AUPH how can you not feel awful for longs here.

Hang in there longs because this one has the potential for huge ROI long term.

Ardelyx Inc

approval

$ARDX what fucking morons are selling it’s approved there are some real dumb fucks involved in this stock good let them get the fuck out. Pussys

$ARDX if we have no approval  you know they are corrupt. .

$ARDX with a 98% chance of fda approval within a few weeks, what is this crap?

Denial of approval of such product  will need a strong justification or presence of significant risk (which is not applicable for Tenapanor as elaborated in the above detailed  
analysis).

but not expecting a ton of juice upon approval 🤞

$ARDX with all due respect, this price action today is embarrassing…nasdaq up 6% we can’t even break $1.30 embarrassing for real… I won’t even be surprised if we get approval next week and we stay stagnant for a bit.

The issue raised was probably one of the only negatives for approval:  The fact that we are using &#39;surrogate&#39; endpoints rather than the correlated clinical outcome.

Tena is already approved for IBS with a solid safety profile, and phosphorus management is a real issue in the CKD community with only binders being available.

insider

One red flag in this company, despite one director buying 1m worth recently, is the low insider ownership.

$ARDX less than one dollar soon insiders doing, given how corrupt the board and CEO are .

$ARDX company doesn’t say anything, insiders don’t buy, stock trades like total crap.

Kind of thing you expect to happen to a stock if the CEO is complicit in a INSIDER Trading SCHEME. .

Those laxatives your taking are not working, you need the full Fleets treatment, a complete system flush.

I still remember listening to the meeting and getting mad at Alikhani, the so called patient&#39;s advocate.

The subsequent increase in intraluminal pressure leads to decreased intestinal blood flow, and in the case of our patient, intestinal ischemia.

They got something that improve the quality of life for dialysis patients and you guys called the trash company.

$ARDX&quot; I am a board-certified nephrologist for 30 years and was very disappointed to say the least by the denial of application of Tenapanor for hyperphosphatemia in patients with CKD.

However, the enrichment strategy did not appear to reliably identify patients who would have a larger treatment response to tenapanor.

As you think about your decision, I’d like to ask you to remember me and the other patients out there like me who are looking for solutions to help them.

Company sitting on the best fundamentals ever to date and we get treated to these stupid 1 liner worthless post.

However when patients get discharged compliance will still remain an issue because nurses and doctors aren’t there watching over them and making sure they take their meds.

trading

Obvious, as hell looking at tape today this trading was far from organic.

↳ Why are you paying to be in a Trading Room?

$ARDX 
With these absurd disconnected 80-100million-share volumes, trading price purely a construction of Dark pool, HFT, MM share-swapping, etc.

In the scientific community as well as in trading feeling get fucked.

reason

what a BS TREE SHAKE by MM&#39;s today was zero reason to let this drop like they did. .

I see no reason to hold or add at this point.

There would be no other reason for the timing.

$ARDX Ok, the only reason to deny our drug is negligible efficacy.

but that the FDA had denied access to for reasons no one understood.

Must be the reason this can’t get past 1.5

There is no reason for it to fall today like this!

He is one of the reasons that the SP stays down.

$ARDX 

“We are in a unique position in the biopharmaceutical industry, demonstrating our status as an evolving, impressive growth story with many opportunities ahead.

We are in a unique position in the biopharmaceutical industry, demonstrating our status as an evolving, impressive growth story with many opportunities ahead.

This is 100% normal and part of the growth of a strong company with excellent fundamentals and an FDA approval coming this year.

$ARDX very good fda news on this conference call

And this is just a beginning, FDA approval will take it to the skies.

Pretty Bullish ER going to give us an update on FDA when and etc. .

If the trend of script numbers is anything to go by, guidance could be way better than Wall Street expects giving us a nice boost before FDA news.

$AKBA within 3  to 4 weeks this stock could be over 2 heading to three like $ARDX .. gsk approval has helped.. fda news, ema opinion/ approval, partnership..

$ARDX when we get fda approval will be shining

This should be seen as a REALLY good thing - because they will need cashflow soon - one would expect - assumption being FDA response is close and production and marketing is about to get kicked up a notch. .

Things to look forward to..  NDA refile announcement, Q4 results, weekly IBSRELA sales increasing now that we are through the holidays, FDA approval, Japan approval, launch of Xphozah.

They just got approval for 1 drug from FDA and things are bot going well there..

$ARDX Looking good, would be nice to finish the day in the 4&#39;s 
 
Still waiting on positive news from the company.

$ARDX just keeps doing things well, and good news should arrive soon!

$ARDX LOL, soon Xenopah News  😁 
Stay in, or buy

$ARDX good news coming man let’s goooooo

Top Stocks matching your search for "industry fda"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Jan, 6, 2023

Oct, 6, 2022

AUPH

Aurinia Pharmaceuticals Inc

3.07%

$8.48 - $8.74

Mar, 20, 2023

Jan, 31, 2023

ARDX

Ardelyx Inc

23.58%

$3.35 - $4.14

Nov, 3, 2022

Nov, 3, 2022

SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Jan, 6, 2023

Oct, 6, 2022

AUPH

Aurinia Pharmaceuticals Inc

3.07%

$8.48 - $8.74

Mar, 20, 2023

Jan, 31, 2023

Jan, 26, 2023

ARDX

Ardelyx Inc

23.58%

$3.35 - $4.14

Nov, 3, 2022

Nov, 3, 2022